EWL news

iShares MSCI Switzerland · Switzerland

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Seeking Alpha · 28 Oct 2026, 18:55 UTC
Roche: Valuation Leaves Limited Upside (OTCMKTS:RHHBF) | Seeking Alpha
14.0% of EWL
Quartz · 28 Oct 2026, 20:39 UTC
Consumer boycotts that worked: 9 that forced change
12.3% of EWL
wallstreet:online · 28 Oct 2026, 14:05 UTC
Sandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidance
13.6% of EWL
Seeking Alpha · 28 Oct 2026, 12:00 UTC
Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking Alpha
13.6% of EWL
Where to buy EWL
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
The Manila times · 28 Oct 2026, 11:10 UTC
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
13.6% of EWL
The Wall Street Journal · 28 Oct 2026, 09:49 UTC
Sandoz Shares Fall After Company Turns Cautious on Sales Guidance
13.6% of EWL
Where to buy EWL
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Investing.com · 28 Oct 2026, 09:35 UTC
Earnings call transcript: Sandoz narrows 2026 sales view after strong Q3 By Investing.com
13.6% of EWL
Bloomberg Business · 28 Oct 2026, 09:34 UTC
Sandoz Warns EU May Scrap Antibiotic Protection, Risking Plant
13.6% of EWL
Investing.com · 28 Oct 2026, 08:36 UTC
Why is Sandoz stock sliding today? By Investing.com
13.6% of EWL
RTTNews · 28 Oct 2026, 07:56 UTC
Sandoz Q3 Sales Rise 4%; Cuts Annual Sales Growth Outlook, But Ups Profit Margin View
13.6% of EWL
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
13.6% of EWL
The Manila times · 28 Oct 2026, 06:07 UTC
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
14.0% of EWL
wallstreet:online · 28 Oct 2026, 06:05 UTC
DKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin From Roche
14.0% of EWL
Reuters · 28 Oct 2026, 06:52 UTC
Generic drugmaker Sandoz lowers sales outlook, lifts profit forecast
13.6% of EWL
Business Standard · 28 Oct 2026, 07:38 UTC
HDFC Bank, ITC, HDFC Life, Nestle, Britannia, TaMo PV hit 52-week lows
12.3% of EWL
Morningstar · 28 Oct 2026, 00:00 UTC
SDZ - Sandoz Group AG Registered Shares Analysis
13.6% of EWL
Investing.com · 27 Oct 2026, 17:22 UTC
Novartis earnings analysis: questions answered and next catalysts By Investing.com
13.6% of EWL
The Irish Times · 27 Oct 2026, 16:25 UTC
Novartis reports $2.2bn hit from drug trial setbacks, but lifts guidance
13.6% of EWL
Benzinga · 27 Oct 2026, 15:38 UTC
Novartis Says 'Well on Track' for Long-Term Outlook Despite $1.9B Avidity Hit - Novartis (NYSE:NVS)
13.6% of EWL
Yahoo! Finance · 27 Oct 2026, 15:16 UTC
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
13.6% of EWL